Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- P/B of 1.14 — trading near book value
- Piotroski F-Score 5/9 — moderate financial health
- Loss-making — negative ROE of -12.6%
- Revenue declining 8% annually
AMN Healthcare Services Inc (AMN) is a Industrials company operating in Services-Help Supply Services, listed on the NYSE , with a market capitalisation of $730 million . Key value metrics: P/B ratio 1.14, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
AMN Healthcare Services Inc — Fundamental Analysis Summary
On financial health, AMN shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -12.6% (sector average: 5.5%), and elevated leverage with a debt-to-equity ratio of 1.19.
StockPik's composite Value Score for AMN is 57/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
AMN reports a moderate gross margin of 29.7% (sector average: 24.7%) and a negative operating margin of -1.5%.
AMN shows revenue declining at 8% year-over-year, with earnings growing at 35%.